BROOKLANDS MEDICAL SUPPLIES Total Infection Control “Millions of Americans are harmed every year by medical errors and healthcare acquired infections that are preventable. The new healthcare reform law will save lives and dollars by... leveraging federal health care dollars to give hospitals a stronger incentive to prevent needless suffering and deaths.” Lisa McGiffert, Director, Consumers Union Safe Patient Project Corporate Overview - Global APPROVED FOR USE
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
BROOKLANDS MEDICAL SUPPLIESTotal Infection Control
“Millions of Americans are harmed every year by medical errors and healthcare acquired infections that are preventable. The new healthcare reform law will save lives and dollars by... leveraging federal health care dollars to give hospitals a stronger incentive to prevent needless suffering and deaths.”
Lisa McGiffert, Director, Consumers Union Safe Patient Project
Corporate Overview - GlobalAPPROVED FOR USE
2
W
E SAVE LIVES
Advanced Biocide Technology Solutions™ (ABTS™)
With the advent of deadly pathogens, bacteria, fungi
and mold affecting populations world wide, Brooklands
Medical Supplies, in partnership with manufacturers
around the world, has produced the world’s most
Advanced Biocide Technology Solutions™.
Our solution uses the most advanced single chemical
compound that produces a seamless protection from
materials to liquids, to human contact to take full
advantage of advanced pathogen destruction. This
global advance brings the ability to accommodate
any requirement in any environment where pathogen
destruction demands a complete solution.
After detailed clinical trials by Campden BRI, two years
of successful use in over 250 hospitals, by UK and
Irish governments and distributed into the UK, China,
Ireland and Germany, Advanced Biocide Technology
Solutions™ are now being released through
Brooklands Medical Supplies to the general population
worldwide.
All BMS ABTS™ products are effective where:
1. Products made of traditional linens are proven to
have high levels of live Pathogens, Bacteria, Fungi
and Molds, that cause human harm or death.1
2. Products known to be in environments where
pathogens, mold or bacteria may be present with a
risk of human contact.
3. Environments where Pathogens, Bacteria, Fungi and
Molds are in direct or indirect contact with humans.
4. Areas where specific activities require custom
development for government and medical safety
environments world wide.
Advanced
3
W
E SAVE LIVES
Conventional versus
Advanced Biocide Technology Solutions™
Conventional linens or plastics wiThOUT inhibitor
technology have been used in the hospital environment for
many years and only recently have been shown as a cause
for hospital acquired infections1.
The introduction of ABTS™ reduces the risk to patients, staff
and visitors of hospital acquired infections by eliminating
99.99999% of pathogens, molds and fungi that come into
contact with the ABTS™2.
Cost Efficiency
in most cases ABTS™ offers a considerable cost saving when
compared to conventional systems:
• Save lives
• Save the planet
• Save on clinical costs
• Save on litigation costs
• Save on infection treatment costs
• Save on labor costs
• Save on laundry costs
• Save on capital costs
Efficient
4
W
E SAVE LIVES
Brooklands at the heart of environmental infection
prevention and control
The heart of the tragedy is that many of the 99,000 annual
deaths in U.S. hospitals resulting from hAis are preventable.
while there are many niche vendors with excellent products
that deal with portions of the environment of care, none
provide a consistent, focused approach tackling the problem
across all environmental sources. Brooklands’ BioGuard™,
the core element of our Advanced Biocide Technology
Solutions™, encompasses the entire environment of care.
Brooklands BioGuard™ products replace traditional and
1. Research 1. Service (F.T., R.B., M.J.P.), the infection Control Department (E.C.E., C.J.D), and the Geriatric Research Education and Clinical Center (C.J.D.), Cleveland Veterans Affairs Medical Center, Cleveland, Ohio2. Report No.: 2. Fh/REP/116479/3a . Evaluation of surfaces for their growth inhibition of methicillin resistant staphylococcus aureus (mrsa), vancomycin resistant enterococcus faecium (vre) & escherichia coli
using the modified Kirby Bauer test. wPRef.:hygiene/2009/Contract/Disposable Cubicle Curtains/Kirby Bauer *Due to the nature of country specific regulatory systems some BMS products are awaiting the necessary approvals.
BROOKLANDS MEDICAL SUPPLIESTotal Infection Control
Please contact:
BROOKLANDS MEDICAL SUPPLIESTotal Infection Control